Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA.VICTOZA® (liraglutide) injection, for subcutaneous useInitial U.S. Approval: 2010
Medication labelWhy this: Advisory · dailymed-prescription
VICTOZA is indicated: •as an adjunct to diet and exercise to improve glycemic control in patients 10 years and older with type 2 diabetes mellitus, •to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease [see Clinical Studies ( 14.3 )]. Limitations of Use: VICTOZA should not be used in patients with type 1 diabetes mellitus. VICTOZA contains liraglutide and should not be coadministered with other liraglutide-containing products.
- generic_name
- liraglutide
- product_names
- liraglutide
- ndc
- 50090-2853, 0169-4060, 50090-2853-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en